GlassScriptPhysician profile
Lawrence O Adu
NPI 1679597702
$2,157.83
in general payments reported to CMS, 2019-2025
20 companies · $371 in 2025
The $371 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $476 · 2020: $259 · 2021: $416 · 2022: $373 · 2023: $220 · 2024: $42.37 · 2025: $371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $633.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $633.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $510.98 | 2021-2025 | Vraylar |
| Neuronetics, INC. | $323.16 | 2019-2025 | Neurostar Tms Therapy System |
| Janssen Pharmaceuticals, INC | $304.68 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $270.08 | 2019-2023 | Rexulti |
| Allergan, INC. | $165.70 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2021 | |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $81.89 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $61.81 | 2022-2023 | Austedo |
| Sunovion Pharmaceuticals INC. | $54.81 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $50.84 | 2023-2024 | Trintellix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.91 | 2021 | |
| Adlon Therapeutics L.P. | $25.41 | 2020 | |
| Lundbeck LLC | $22.01 | 2023 | Rexulti |
| Collegium Pharmaceutical, INC. | $21.36 | 2025 | Jornay Pm |
| Orexo US, INC. | $17.64 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $16.36 | 2020 | |
| Jazz Pharmaceuticals INC. | $16.16 | 2019 | |
| Almatica Pharma LLC | $14.98 | 2022 | |
| Mdd US Operations, LLC | $14.39 | 2020 | |
| Bausch Health US, LLC | $13.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lawrence Adu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.